Table II.
Groups | Microscopic lymphoid lzesion scores | Microscopic lung lesion scores | Number of PCV-2 antigen- positive cells |
---|---|---|---|
Single-infection | |||
PCV-2a | 1.50 ± 0.35a | 0.80 ± 0.30a | 16.67 ± 2.00a |
PCV-2b | 1.50 ± 0.35a | 1.00 ± 0.15a | 18.44 ± 3.53a |
PCV-2d | 1.70 ± 0.35a | 1.00 ± 0.30a | 17.89 ± 4.17a |
PCV-2e | 1.20 ± 0.15a | 0.90 ± 0.20a | 12.39 ± 1.41b |
Negative control | 0.00 ± 0.00b | 0.00 ± 0.00b | 0.00 ± 0.00c |
Dual-infection | |||
PCV-2a/PRRSV | 3.20 ± 0.45a | 2.60 ± 1.00a,b | 31.17 ± 3.42a |
PCV-2b/PRRSV | 3.30 ± 0.35a | 2.90 ± 0.20a | 30.17 ± 7.43a |
PCV-2d/PRRSV | 3.60 ± 0.15b | 3.30 ± 0.65a | 41.72 ± 5.20b |
PCV-2e/PRRSV | 2.70 ± 0.20a | 2.60 ± 0.15b | 14.17 ± 4.04c |
PRRSV | 1.00 ± 0.45c | 2.20 ± 0.45b | 0.00 ± 0.00d |
Negative control | 0.00 ± 0.00d | 0.00 ± 0.00c | 0.00 ± 0.00d |
Different superscripts (a, b, c, and d) indicate significant (P < 0.05) difference among either single-infected or dual-infected groups. Microscopic lymphoid and lung lesion scores: median ± interquartile range (IQR) and number of PCV-2 antigen-positive cells: mean ± standard deviation (SD).